FATE CIK: 1434316

Fate Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.63
FY22:
0.50
FY23:
0.33
FY24:
0.29
FY25:
0.21
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.29
FY22:
0.20
FY23:
0.17
FY24:
0.15
FY25:
0.11
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.92
FY22:
0.71
FY23:
0.51
FY24:
0.44
FY25:
0.32

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.08
FY22:
0.11
FY23:
0.04
FY24:
0.04
FY25:
0.04
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.16
FY22:
0.11
FY23:
0.10
FY24:
0.08
FY25:
0.08
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.68
FY22:
0.48
FY23:
0.37
FY24:
0.32
FY25:
0.21
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.92
FY22:
0.71
FY23:
0.51
FY24:
0.44
FY25:
0.32

All amounts in billions USD Data sources:SEC EDGARTwelve Data